Cargando…

Lipoprotein(a): A Taxi for Autotaxin Takes a Toll in Calcific Aortic Valve Disease

[Figure: see text]

Detalles Bibliográficos
Autor principal:	Towler, Dwight A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Editorial Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6034448/ https://www.ncbi.nlm.nih.gov/pubmed/30062146 http://dx.doi.org/10.1016/j.jacbts.2017.05.002

Ejemplares similares

Off Target But on Track to New Strategies to Mitigate Calcific Aortic Valve Disease
por: Towler, Dwight A.
Publicado: (2019)

Autotaxin and Lipoprotein Metabolism in Calcific Aortic Valve Disease
por: Mathieu, Patrick, et al.
Publicado: (2019)

Interaction of Autotaxin With Lipoprotein(a) in Patients With Calcific Aortic Valve Stenosis
por: Bourgeois, Raphaëlle, et al.
Publicado: (2020)

Lysophospholipids in the limelight: autotaxin takes center stage
por: Moolenaar, Wouter H.
Publicado: (2002)

PCSK9 and Calcific Aortic Valve Stenosis: Moving Beyond Lipids
por: Leopold, Jane A.
Publicado: (2020)

Lipoprotein(a) as Orchestrator of Calcific Aortic Valve Stenosis
por: Schnitzler, Johan G., et al.
Publicado: (2019)

Toll-Like Receptors, Inflammation, and Calcific Aortic Valve Disease
por: García-Rodríguez, Carmen, et al.
Publicado: (2018)

Lipoprotein(a), a Lethal Player in Calcific Aortic Valve Disease
por: Hu, Jiahui, et al.
Publicado: (2022)

Health Behaviors and Calcific Aortic Valve Disease
por: Lamprea‐Montealegre, Julio A., et al.
Publicado: (2018)

Lipoprotein(a) is associated with the onset but not the progression of aortic valve calcification( )
por: Kaiser, Yannick, et al.
Publicado: (2022)

Aortic arch calcification: A simple but powerful marker of subclinical cardiovascular disease
por: Qazi, Saadia, et al.
Publicado: (2022)

Lipoprotein(a) Induces Human Aortic Valve Interstitial Cell Calcification
por: Yu, Bin, et al.
Publicado: (2017)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
por: Burdeynaya, Anna L., et al.
Publicado: (2023)

Ancient Remedy for a Modern Disease: Will Celastrol Become a Treatment for Aortic Valve Stenosis?
por: Yeang, Calvin, et al.
Publicado: (2020)

Novel insights into the molecular basis of calcific aortic valve disease
por: Rysä, Jaana
Publicado: (2020)

Lipoprotein(a): An Enigmatic Sheep in the Lipoprotein Herd
por: Shapiro, Michael D., et al.
Publicado: (2020)

Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic Stenosis
por: Zheng, Kang H., et al.
Publicado: (2019)

Lipoprotein(a): Its Association with Calcific Aortic Valve Stenosis, the Emerging RNA-Related Treatments and the Hope for a New Era in “Treating” Aortic Valve Calcification
por: Tsamoulis, Donatos, et al.
Publicado: (2023)

Lipoprotein(a) Gene Polymorphism Increases a Risk Factor for Aortic Valve Calcification
por: Ozkan, Ugur, et al.
Publicado: (2019)

Lipoprotein(a) and progression of aortic valve calcification: a case of collider bias? Reply
por: Kaiser, Yannick, et al.
Publicado: (2023)

Lipoprotein(a)-Associated Molecules Are Prominent Components in Plasma and Valve Leaflets in Calcific Aortic Valve Stenosis
por: Torzewski, Michael, et al.
Publicado: (2017)

Association Between Lipoprotein(a) and Calcific Aortic Valve Disease: A Systematic Review and Meta-Analysis
por: Liu, Qiyu, et al.
Publicado: (2022)

Editorial: We need more national data on transcatheter aortic valve implantation
por: Barçın, Cem
Publicado: (2020)

Ross procedure in bicuspid aortic valve pathologies
por: Misfeld, Martin, et al.
Publicado: (2022)

The role of valve interstitial cells in valve disease
por: Feng, Yang, et al.
Publicado: (2016)

Should Aortic Valve Calcification be Checked Before Percutaneous Coronary Intervention?
por: Kaji, Shuichiro
Publicado: (2017)

Pelacarsen for lowering lipoprotein(a): implications for patients with chronic kidney disease
por: Fernandez-Prado, Raul, et al.
Publicado: (2020)

Association Between Plasma Lipoprotein Levels and Aortic Valve Calcification Among Patients with Aortic Valve Replacement Surgery: A Retrospective Study
por: Tao, Tingting, et al.
Publicado: (2022)

The Role of Index of Valvular-Arterial Impedance and Systemic Arterial Compliance after Aortic Valve Replacement
por: Park, Sung-Ji
Publicado: (2016)

Cholesterol efflux promoting function of high-density lipoproteins in calcific aortic valve stenosis
por: Kocyigit, Duygu, et al.
Publicado: (2021)

NOTCH Signaling in Aortic Valve Development and Calcific Aortic Valve Disease
por: Wang, Yidong, et al.
Publicado: (2021)

Coronary artery calcification: does it predict obstructive coronary artery disease?
por: Dharampal, A. S., et al.
Publicado: (2013)

Correlations between lipoprotein(a) gene polymorphisms and calcific aortic valve disease and coronary heart disease in Han Chinese
por: Dong, Hongzhi, et al.
Publicado: (2020)

Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease
por: Sikura, Katalin Éva, et al.
Publicado: (2019)

Lipoprotein (a): A Frustrating Final Frontier in Lipid Management?
por: Libby, Peter
Publicado: (2016)

Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosis
por: Kaiser, Yannick, et al.
Publicado: (2022)

Megalin/lipoprotein receptor-related protein 2 autoimmunity and kidney disease
por: Perez-Gomez, Maria V, et al.
Publicado: (2020)

Animal Models of Calcific Aortic Valve Disease
por: Sider, Krista L., et al.
Publicado: (2011)

Transcatheter aortic valve implantation: first choice for aortic stenosis?
por: den Heijer, P.
Publicado: (2020)

Effects of Apolipoprotein A-I/High-Density Lipoprotein Cholesterol on Atherosclerotic Vascular Disease: Critical Impact of Atherosclerosis Disease Stage and Disease Milieu?
por: Haghikia, Arash, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_8ah47kbieooi0288h3us222qtf